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Breast cancer remains the most common cancer diagnosed in women. Axillary lymph node dissection 
is necessary part of modified radical mastectomy (MRM). Lymphorrhea (LR)  and seroma formation are 
disabling and serious complications of axillary lymphadenectomy. 
Aim: The role of octreatide in control of post radical mastectomy (Madden) lymphorrhea will be 
assessed in this study. 
Methods: 30 female patients with breast cancer of different stages after MRM , which were operated 
in SROD in 2013 year, were divided into two groups: the first (12) – was given octreatide 0.1 mg s/c for 
seven days, the other (18) – was the control. Both groups were evaluated for amount and duration of LR. 
Results: A significant difference in the amount and duration of LR between two groups was observed 
(P < 0.05). In control group the mean duration of LR was 27.0  1.4 days, the mean amount of LR in the 
first 7 days was 143  2.1ml per day. In the treatment group the mean amount of LR p.d. during first 7 
days decreased to 103  2.5ml, and the mean duration of LR decreased to 13.2  1.8 days. 
Conclusion: Octreatide inhibit lymphatic production and could be used successfully for control of 
post MRM lymphorrhea. 
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